Scholarlink

Background <p>Immunotherapy has demonstrated promising results in treating colorectal cancer (CRC), yet not all patients benefit equally, highlighting the need for predictive biomarkers and additional adjuvant. Neutrophils, pivotal in immune regulation and inflammation, remain underexplored in the context of CRC immunotherapy, holding the potential targets for improving immunotherapy efficacy.</p> Methods <p>Single-cell RNA sequencing data from 19 CRC patients, including immunotherapy-treated individuals and controls, were analyzed. Genes associated with neutrophil differentiation, termed Neutrophil Differentiation-Related Genes (NDRGs), were identified through trajectory analysis and refined to nine genes (TMBIM6, CTSS, CYCS, DDX3X, DYNLL1, LGALS1, GANI2, RPS29, and TUBA1A) using Elastic Net. Drug screening was performed to identify potential therapeutic agents targeting NDRGs.</p> Results <p>Immunotherapy induced a shift in neutrophil composition, marked by a reduction in inflammatory neutrophils and an increase in immune neutrophils. The nine NDRGs were successfully validated and utilized to develop a predictive model for immunotherapy response. Drug screening identified Ivermectin as a potential therapeutic agent targeting NDRGs.</p> Conclusions <p>This study highlights the dynamic role of neutrophils in the CRC immune microenvironment, their potential as biomarkers for immunotherapy response, and their utility as therapeutic targets to improve immunotherapy outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Single-cell RNA sequencing reveals neutrophil differentiation-related genes for immunotherapy response prediction in colorectal cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月22日

查看全文
  • Lishi Wang,
  • Hongyuan Wu,
  • Yanru Chen,
  • Gang Wang,
  • Shaofang Ren,
  • Yan Zhang,
  • Jiao Zhou,
  • Jiefang He,
  • Jialuo Chen,
  • Xuefang Zhang

摘要

Background

Immunotherapy has demonstrated promising results in treating colorectal cancer (CRC), yet not all patients benefit equally, highlighting the need for predictive biomarkers and additional adjuvant. Neutrophils, pivotal in immune regulation and inflammation, remain underexplored in the context of CRC immunotherapy, holding the potential targets for improving immunotherapy efficacy.

Methods

Single-cell RNA sequencing data from 19 CRC patients, including immunotherapy-treated individuals and controls, were analyzed. Genes associated with neutrophil differentiation, termed Neutrophil Differentiation-Related Genes (NDRGs), were identified through trajectory analysis and refined to nine genes (TMBIM6, CTSS, CYCS, DDX3X, DYNLL1, LGALS1, GANI2, RPS29, and TUBA1A) using Elastic Net. Drug screening was performed to identify potential therapeutic agents targeting NDRGs.

Results

Immunotherapy induced a shift in neutrophil composition, marked by a reduction in inflammatory neutrophils and an increase in immune neutrophils. The nine NDRGs were successfully validated and utilized to develop a predictive model for immunotherapy response. Drug screening identified Ivermectin as a potential therapeutic agent targeting NDRGs.

Conclusions

This study highlights the dynamic role of neutrophils in the CRC immune microenvironment, their potential as biomarkers for immunotherapy response, and their utility as therapeutic targets to improve immunotherapy outcomes.